Analytical profile of the new diuretic beta-blocking agent tienoxolol hydrochloride
Guechot, C.; Bertrand, A.; Cramaille, P.; Teulon, J.M.
Arzneimittel-Forschung 38(5): 655-660
1988
ISSN/ISBN: 0004-4172 PMID: 2901263 Document Number: 310863
Physicochemical properties, i.e. elemental analysis, spectra (NMR, MS, IR, UV), solubilities, pKa, partition coefficient, melting point, HPLC, and data on purity and stability of ethyl 2-(3-[(1,1-dimethylethyl)amino]-2-hydroxy-propoxy)-5-[(2- thienylcarbonyl)amino]benzoate hydrochloride (tienoxolol), a new drug with antihypertensive properties are reported.
Document emailed within 1 workday
Related Documents
Linée, P.; Le Pollès, J.B.; Lacroix, P.; Pape, D.; Quiniou, P.; Van den Driessche, J. 1977: Effects of a beta-adrenolytic and a diuretic vis-à-vis hyper-reninemia induced by isoprenaline in anesthetized dogs. Value of beta blocking-diuretic interaction Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 171(1): 218-223Hara, Y.; Sato, E.; Miyagishi, A.; Aono, S.; Nakatani, H. 1979: Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 707-720
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Cascone, A.; Ferrari, F.; Alaimo, A.; Daprati, A.; Cascone, G. 1985: Treatment of arterial hypertension with a calcium-channel blocking agent, nicardipine hydrochloride Bollettino Chimico Farmaceutico 124(5): 37S-42S
Naess, K. 1973: A beta blocking agent as an antihypertensive agent Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2041
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity Arzneimittel-Forschung 34(3): 270-276
Lewis, B.S.; Bakst, A.; Kitchiner, D.; Gotsman, M.S. 1973: Effectiveness of sectral (M and B 17803A) as a beta-blocking agent in man South African Medical Journal 47(27): 1181-1184
Dal Palu, C. 1971: Sudden death during treatment by beta-blocking agent Annales de Cardiologie et d'Angeiologie 20(1): 69-70
Ishii, M.; Komori, S.; Satoh, H.; Ohta, T.; Motomura, S.; Hashimoto, K. 1984: Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 84(3): 259-266
Hansson, L.; Henningsen, N.C.; Jameson, S.; Karlberg, B.E.; Westerlund, A.; Aberg, H. 1976: Clinical testing of a new beta blocking agent--atenolol--in hypertension Lakartidningen 73(34): 2741-2744
Neviani, V.; Tosi, P.; Prampolini, M.L. 1976: 1st experiences with the clinical use of a new beta-blocking agent (tolamolol) in some heart diseases La Clinica Terapeutica 77(5): 451-458
Di Veroli, C.; Compagno, S. 1982: Clinical evaluation of a beta-blocking agent in a single daily dose La Clinica Terapeutica 101(6): 623-628
Salmini, G.; Cione, R.; Oldrini, R. 1970: Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative Minerva Cardioangiologica 18(5): 311-315
Bricaire, H.; Pandos 1971: Clinical study on the action of a beta blocking agent (LB 46) on some manifestations of hyperthyroidism and hypothyroidism La Presse Medicale 79(51): 2301-2304
Kirch, W.; Von Gizycki, C. 1980: Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances International Journal of Clinical Pharmacology Therapy and Toxicology 18(5): 233-235
Baïsset, A.; Dang-Tran, L.; Montastruc, P. 1971: Effect of an adrenergic beta-blocking agent on adrenaline-induced hyperglycemia in hypophysectomized dogs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(11): 2209-2214
Srivastava, B.N.; Jain, P.C.; Vyas, G.P. 1972: A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial) Indian Heart Journal 24(Suppl 1): 203-204
Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98